Bayer Aspirin Ads Revised Under $1 Mil. FTC Settlement

Bayer ads cautioning aspirin therapy "is not appropriate for everyone" and offering a free consumer education brochure will break in February magazines under a $1 mil. settlement reached with the Federal Trade Commission.